By
MikeH on
March 6, 2013
Almost two years after getting regulatory OK to sell a new partially-disposable insulin pump in the U.S., a California company has changed the name of its product just before it hits the market in April.
The Asante Pearl will now be known as the Asante Snap, a pretty spot-on name since it’s not only short and snappy (pun intended!) but also accurately describes the design concept of this new “click-and-connect” insulin pump!
Yes, it pops…
Read more »
By
MikeH on
February 12, 2013
We already have the ability to use a global positioning system when we’re behind the wheel, not only plotting out where we are on the road but also to find out what turns to make next on the drive to wherever we’re heading.
Now, take that idea into the world of diabetes management.
Think of that GPS helping you automatically map out your insulin treatment, charting glucose readings and suggesting what doses you might need…
Read more »
By
WilD on
February 7, 2013
News broke the other day that Tandem Diabetes had gobbled up 51 patents belonging to Smiths Medical ASD, the folks who made the Deltec Cozmo pump that’s been off the market for almost four years now. Officials from both companies are tight-lipped on what this means, but it seems to imply that future versions of the slick new Tandem t:slim pump might utilize some legacy Cozmo technology…
Meanwhile, we got word in early January that…
Read more »
By
MikeH on
February 5, 2013
Many in the Diabetes Community are anxiously awaiting the release of the smaller and sleeker 2nd generation OmniPod, but already we know what a third generation won’t have:
A Pod that’s integrated with a Dexcom CGM sensor.
Yep, it’s true: the two companies say they have abandoned the integration deal they had in place since 2008.
Two executives at Massachusetts-based Insulet Corp., makers of the OmniPod, say they’re no longer working with California-based Dexcom on…
Read more »
By
AmyT on
January 31, 2013
The fact is, a handful of manufacturers currently have a stronghold on our diabetes data. Their systems collect this vital health data for us, but are designed to withhold it so that we rely on their products exclusively to access it, share it, or analyze it.
More and more patients are finding this intolerable, and are fed up with waiting for the Pharma industry to embrace long-overdue open standards.
I’m a bit obsessed with this…
Read more »
